Literature DB >> 17129957

Kostmann syndrome or infantile genetic agranulocytosis, part one: celebrating 50 years of clinical and basic research on severe congenital neutropenia.

Göran Carlsson1, Mats Andersson, Katrin Pütsep, Daniel Garwicz, Magnus Nordenskjöld, Jan-Inge Henter, Jan Palmblad, Bengt Fadeel.   

Abstract

UNLABELLED: Congenital neutropenia in man was first reported 50 years ago by the Swedish paediatrician Rolf Kostmann. He coined the term "infantile genetic agranulocytosis" for this condition, which is now known as Kostmann syndrome. Recent studies have demonstrated a lack of antibacterial peptides and severe periodontitis in these patients despite recombinant growth factor treatment. Moreover, an increased degree of apoptosis of myeloid progenitor cells in the bone marrow has been shown.
CONCLUSION: Future studies should aim to clarify the underlying molecular genetic defect in Kostmann syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 17129957     DOI: 10.1080/08035250601087607

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  10 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  A novel compound heterozygous HAX1 mutation in a Chinese patient with severe congenital neutropenia and chronic myelomonocytic leukemia transformation but without neurodevelopmental abnormalities.

Authors:  Sheng-Li Xue; Jin-Li Li; Jing-Ying Zou; Jian Su; Su-Ning Chen; De-Pei Wu
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

3.  A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations.

Authors:  Muhammad Faiyaz-Ul-Haque; Abdullah Al-Jefri; Fouad Al-Dayel; Jalaluddin A K M Bhuiyan; Hala A Abalkhail; Randa Al-Nounou; Ahmed Al-Abdullatif; Monogaran S Pulicat; Ameera Gaafar; Ayodele A Alaiya; Iskra Peltekova; Syed H E Zaidi
Journal:  Eur J Pediatr       Date:  2010-02-25       Impact factor: 3.183

4.  Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Authors:  Daniel Tesfa; Tobias Gelius; Birgitta Sander; Eva Kimby; Bengt Fadeel; Jan Palmblad; Hans Hägglund
Journal:  Med Oncol       Date:  2008-02-16       Impact factor: 3.064

Review 5.  Eponym. Kostmann disease.

Authors:  Caner Aytekin; Manuela Germeshausen; Nilden Tuygun; Gonul Tanir; Figen Dogu; Aydan Ikinciogullari
Journal:  Eur J Pediatr       Date:  2010-02-18       Impact factor: 3.183

6.  A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years.

Authors:  Neil Marlow; Timothy Morris; Peter Brocklehurst; Robert Carr; Frances Cowan; Nishma Patel; Stavros Petrou; Margaret Redshaw; Neena Modi; Caroline J Doré
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-04-28       Impact factor: 5.747

7.  The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective study.

Authors:  Ying Ye; Göran Carlsson; Jenny M T Karlsson-Sjöberg; Niels Borregaard; Thomas U Modéer; Mats L Andersson; Katrin L-A Pütsep
Journal:  Sci Rep       Date:  2015-06-29       Impact factor: 4.379

Review 8.  Primary immunodeficiencies associated with eosinophilia.

Authors:  Behdad Navabi; Julia Elizabeth Mainwaring Upton
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

9.  Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis.

Authors:  Louise Strandberg; Margareta Verdrengh; Maria Enge; Niklas Andersson; Sylvie Amu; Karin Onnheim; Anna Benrick; Mikael Brisslert; Johan Bylund; Maria Bokarewa; Staffan Nilsson; John-Olov Jansson
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

Review 10.  Human defensins and LL-37 in mucosal immunity.

Authors:  Mona Doss; Mitchell R White; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  J Leukoc Biol       Date:  2009-10-06       Impact factor: 4.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.